Ignite Creation Date:
2025-12-26 @ 12:19 PM
Ignite Modification Date:
2025-12-29 @ 7:29 PM
Study NCT ID:
NCT01025700
Status:
COMPLETED
Last Update Posted:
2011-02-17
First Post:
2009-12-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nabilone & Marijuana Addiction
Sponsor:
University of British Columbia
Organization:
Study Overview
Official Title:
A Double-Blind Placebo Control Study on the Use of Nabilone for Outpatient Management of Acute Marijuana Withdrawal
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Safety of Nabilone in reducing marijuana craving
Detailed Description:
Randomized double blind trial into the safety and efficacy of Cesemat for the treatment of marijuana use
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: